Dow Up 1.57% Nasdaq Up 2.12%

Inovio Pharmaceuticals, Inc. (INO)

-NasdaqGS
9.21 Up 0.92(11.10%) Jun 28, 4:00PM EDT
|After Hours : 9.34 Up 0.13 (1.41%) Jun 28, 7:21PM EDT
Prev Close:8.29
Open:8.50
Bid:9.30 x 800
Ask:9.37 x 900
1y Target Est:15.50
Beta:2.89872
Earnings Date:Aug 8 - Aug 12 (Est.)
Day's Range:8.45 - 9.27
52wk Range:4.50 - 11.69
Volume:2,190,374
Avg Vol (3m):1,818,280
Market Cap:675.53M
P/E (ttm):N/A
EPS (ttm):-0.38
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INOUp 11.10%675.53M
PFEUp 1.89%208.87B
AZNUp 4.08%73.60B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.93
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.75
Quarterly EPS Est (Jun-16) :-0.21
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback